These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17468770)

  • 1. Parvovirus B19 pneumonia in a child undergoing allogeneic hematopoietic stem cell transplantation.
    Beske F; Modrow S; Sörensen J; Schmidt H; Kriener S; Allwinn R; Klingebiel T; Schwabe D; Lehrnbecher T
    Bone Marrow Transplant; 2007 Jul; 40(1):89-91. PubMed ID: 17468770
    [No Abstract]   [Full Text] [Related]  

  • 2. Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia.
    Zohren F; Czibere A; Bruns I; Fenk R; Schroeder T; Gräf T; Haas R; Kobbe G
    Bone Marrow Transplant; 2009 Dec; 44(12):785-92. PubMed ID: 19430496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation.
    Kim JH; Stein A; Tsai N; Schultheiss TE; Palmer J; Liu A; Rosenthal J; Forman SJ; Wong JY
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):75-81. PubMed ID: 24725691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double allogeneic peripheral blood stem cell transplantation in a 9-year-old patient with relapsed acute lymphoblastic leukemia: case report.
    Fujii H; Goto H; Watanabe Y; Yamazaki S; Takahashi H; Sekiguchi H; Funabiki T; Ikuta K; Yokota S
    Pediatr Hematol Oncol; 2004; 21(3):261-5. PubMed ID: 15202165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation.
    Grüllich C; Bertz H; Spyridonidis A; Müller CI; Finke J
    Bone Marrow Transplant; 2008 May; 41(10):845-50. PubMed ID: 18209719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.
    Huck K; Laws HJ; Meisel R; Traeger A; Bernbeck B; Schonberger S; Stackelberg VA; Pape H; Dilloo D
    Haematologica; 2006 May; 91(5 Suppl):ECR07. PubMed ID: 16709515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of high-dose etoposide administered in combination with fractionated total-body irradiation as conditioning for allogeneic hematopoietic stem cell transplantation in children with acute lymphoblastic leukemia.
    Chrzanowska M; Sobiak J; Grund G; Wachowiak J
    Pediatr Transplant; 2011 Feb; 15(1):96-102. PubMed ID: 21159109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily intravenous busulfan-fludarabine-etoposide regimen in pediatric and infant acute lymphoblastic leukemia patients.
    Lee JW; Kang HJ; Kim S; Lee SH; Yu KS; Kim NH; Jang MK; Kim H; Song SH; Park JD; Park KD; Shin HY; Jang IJ; Ahn HS
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):190-5. PubMed ID: 25255163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipients.
    Muetherig A; Christopeit M; Müller LP; Grothe W; Weber T; Theurich S; Behre G
    Bone Marrow Transplant; 2007 Mar; 39(5):315-6. PubMed ID: 17311086
    [No Abstract]   [Full Text] [Related]  

  • 10. The outcome of allogeneic hematopoietic stem cell transplants without total body irradiation in pediatric patients with acute lymphoblastic leukemia: single centre experience.
    Hamidieh A; Kargar M; Jahani M; Alimoghaddam K; Bahar B; Mousavi SA; Iravani M; Jalali A; Jalili M; Ghavamzadeh A
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):101-7. PubMed ID: 22367385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients.
    Gonzalez-Vicent M; Perez A; Abad L; Sevilla J; Ramirez M; Diaz MA
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e85-90. PubMed ID: 20216238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study.
    Bunin N; Aplenc R; Kamani N; Shaw K; Cnaan A; Simms S
    Bone Marrow Transplant; 2003 Sep; 32(6):543-8. PubMed ID: 12953124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation-free allogeneic conditioning with fludarabine, carmustine, and thiotepa for acute lymphoblastic leukemia and other hematologic malignancies necessitating enhanced central nervous system activity.
    Christopoulos P; Bertz H; Ihorst G; Marks R; Wäsch R; Finke J
    Biol Blood Marrow Transplant; 2012 Sep; 18(9):1430-7. PubMed ID: 22430085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.
    van Besien K; Devine S; Wickrema A; Jessop E; Amin K; Yassine M; Maynard V; Stock W; Peace D; Ravandi F; Chen YH; Cheung T; Vijayakumar S; Hoffman R; Sosman J
    Bone Marrow Transplant; 2003 Jul; 32(1):9-13. PubMed ID: 12815472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan Society for Hematopoietic Cell Transplantation.
    Kato M; Ishida H; Koh K; Inagaki J; Kato K; Goto H; Kaneko T; Cho Y; Hashii Y; Kurosawa H; Takita J; Hamamoto K; Inoue M; Sawada A; Suzuki R; Kato K
    Pediatr Blood Cancer; 2015 Oct; 62(10):1844-50. PubMed ID: 26053959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treosulfan-fludarabine-thiotepa conditioning before allogeneic haemopoietic stem cell transplantation for patients with advanced lympho-proliferative disease. A single centre study.
    Baronciani D; Depau C; Targhetta C; Derudas D; Culurgioni F; Tandurella I; Latte G; Palmas A; Angelucci E
    Hematol Oncol; 2016 Mar; 34(1):17-21. PubMed ID: 25626861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India.
    Choudhary D; Sharma SK; Gupta N; Kharya G; Pavecha P; Handoo A; Setia R; Katewa S
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):492-5. PubMed ID: 23160007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. bcr-abl-positive T-cell acute lymphoblastic leukemia associated with parvovirus B19 infection.
    Abla O; Gassas A; Stevens R; Grant R; Abdelhaleem M
    J Pediatr Hematol Oncol; 2006 Feb; 28(2):98-9. PubMed ID: 16462583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide.
    Frangoul H; Evans M; Isbell J; Bruce K; Domm J
    Bone Marrow Transplant; 2018 May; 53(5):647-650. PubMed ID: 29339800
    [No Abstract]   [Full Text] [Related]  

  • 20. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.